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Abstract The conventional method of culturing human embryonic stem cells (hESC) is on two-dimensional (2D) surfaces,
which is not amenable for scale up to therapeutic quantities in bioreactors. We have developed a facile and robust
method for maintaining undifferentiated hESC in three-dimensional (3D) suspension cultures on matrigel-coated
microcarriers achieving 2- to 4-fold higher cell densities than those in 2D colony cultures. Stable, continuous propagation
of two hESC lines on microcarriers has been demonstrated in conditioned media for 6 months. Microcarrier cultures (MC)
were also demonstrated in two serum-free defined media (StemPro and mTeSR1). MC achieved even higher cell
concentrations in suspension spinner flasks, thus opening the prospect of propagation in controlled bioreactors.
© 2009 Elsevier B.V. All rights reserved.Introduction
Recent progress in the development of defined serum-free,
feeder-free culture systems (Ludwig et al., 2006; Ding et al.,
2006; Chase and Firpo, 2007) provides one part of the
solution to a multifaceted puzzle that will enable progress to
be made in the production and clinical application of human
embryonic stem cells (hESC) in cell therapy. Another majorAbbreviations: BSA/PBS, bovine serum albumin/phosphate-buf-
fered saline; 2D, two-dimensional; 3D, three-dimensional; hESC,
human embryonic stem cells; MC, microcarrier cultures; mESC,
mouse embryonic stem cells.
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doi:10.1016/j.scr.2009.02.005limitation is that the vast majority of culture methods are
still on two-dimensional (2D) plastic surfaces. Ideally, if hESC
could be propagated in suspension culture, without the
limitation of a flat surface, this will enable translation into
controlled bioreactors which could be used in industrial
manufacturing. However, except for a few studies of mouse
embryonic stem cells on microcarriers (Fernandes et al.,
2007; Abranches et al., 2007; King and Miller, 2007) and
differentiating hESC in suspension culture as embryoid
bodies (Dang et al., 2004; Fok and Zandstra, 2005; Cameron
et al., 2006; Yirme et al., 2008), there is no robust method of
long-term, serial culturing of hESC in suspension culture. A
recent publication (Phillips et al., 2008b) has demonstrated
proof of concept of culturing hESC on microcarriers by
seeding aggregates as well as single cells. Initially, 3-fold
expansion was achieved over 5 days; however, with each
successive passage cell expansion was reduced until cells.
220 S.K.W. Oh et al.could not be passaged beyond Week 6 (Phillips et al., 2008b).
We evaluated an extensive range of microcarriers and found
that they were unable to maintain hESC for more than 10
passages. However, rod-shaped, cellulose microcarriers we
subsequently tested were capable of long-term culture of
hESC.
In this study, we demonstrate robust, serial culture and
passaging of hESC on microcarriers while retaining their
pluripotent markers. Growth kinetics and metabolism of
microcarriers cultures (MC) were compared with 2D colony
cultures and suspension MC of hESC was demonstrated with
two cell lines.
Results
Passaging and stable propagation of hESC cultures
on microcarriers
We have demonstrated that matrigel-coated cellulose MC,
like 2D colony cultures, allowed simple and routine passaging
of hESC without differentiation. This passaging can be
performed easily by both mechanical dissociation (by passing
through a 100-μm mesh or by manual pipetting) and
enzymatic dissociation (TrypLE enzyme or collagenase)
methods. MC can be seeded directly from 2D colony cultures
or reseeded from MC to 2D colony cultures (Supplementary
Fig. 1b). The expressions of the three canonical markers of
pluripotency, Oct4, SSEA4, and TRA-1-60, after passaging of
HES-3 cells by these methods are equivalent to those of the
control 2D colony culture (Supplementary Fig. 1c). The cell
densities achieved in MC passaged by mechanical or enzy-
matic methods were similar (data not shown). Characteriza-
tion assays that were performed periodically on MC are
presented in Supplementary Fig. 1d.
After mechanical passage of hESC MC, the cells rapidly
colonized the matrigel-coated microcarriers on Day 1 and
became fully confluent cell-microcarrier aggregates on Day
6. In uncoated MC, hESC grew but underwent rapid
differentiation, observed by loss of pluripotent markers
(data not shown) and generation of cystic regions within the
cell-microcarrier aggregates (Fig. 1a). Histological analysis
of matrigel-coated MC shows that hESC form multilayers of
cells on the microcarriers and all of the cells stained positive
for TRA-1-60, whereas uncoated MC have vacuoles within the
cell aggregates and weak staining of TRA-1-60 (Fig. 1b).
When hESC MC were replated onto 2D colony cultures, they
spread onto the matrigel-coated surface and increased inFigure 1 Culture and passaging of HES-3 hESC onmicrocarriers (sta
coated microcarriers attach efficiently to the surface of the microca
Day 6. Uncoated microcarriers show cystic regions (white arrows)
sections of the matrigel-coated microcarrier cell aggregates show ev
as shown by the DAPI nuclear stain and the hESC specific marker,
microcarriers have distinct vacuoles within the cell aggregates
microcarriers and white arrows indicate TRA-1-60 staining of hESC.
replated on 2D surface at low density. Dark arrows show hESC micr
matrigel-coated plates. Passage 6. Scale bar, 1 mm. Replated hESC e
and viability is N90%. Cells were stained with SSEA-1 as the isotype
1.8×106 cells/ml were achieved at weekly passages. Duplicate pass
shown. Pluripotent markers Oct4, SSEA4, and TRA-1-60 were robustly
with SSEA-1 as the isotype control.cell density by 4-fold over 7 days, with greater than 90%
viability and continued to express the three stem cell
markers, Oct4, SSEA4, and TRA-1-60 (Fig. 1c). After 9
weeks of continuous passaging, hESC still retained high
expression levels of these pluripotent markers and typi-
cally achieved 1.2 to 1.8 million cells/ml in a 6-well plate
with viability above 90% (Fig. 1d). Normal karyotype of
MC propagated in conditioned media up to 25 passages
(6 months) was demonstrated for two cell lines (HES-2 and
HES-3). Fig. 2a shows that the karyotype for HES-2 and HES-3
at passages 14 and 25, respectively, remains normal. MC
retained their ability to differentiate into embryoid bodies
with cells expressing genes from the ectoderm, mesoderm,
and endoderm (Fig. 2b) and also formed teratomas in SCID
mice with tissues representing the three germ layers
(Fig. 2c). In addition, hESC on MC were able to form beating
aggregates indicative of cardiomyocytes in serum-free media
(Supplementary Fig. 2).Growth kinetics of microcarrier cultures
Growth kinetics and metabolism of MC in conditioned media
were compared with conventional 2D colony cultures. The 2D
colony cultures typically attained maximal confluent cell
density of 0.8 million cells/ml (or 4 million cells/well in a
6-well plate) by Day 5. Whereas MC continued growing,
reaching twice the cell densities of 1.6 million cells/ml by
Day 7, due to the increased surface area available for 3D
growth as cell-microcarrier aggregates (Fig. 3a). Daily
glucose and glutamine consumption and lactate and ammo-
nium production levels were similar for both cultures
(Fig. 3b). At the start of each day, 80% of fresh medium is
added to each culture; hence glucose and glutamine are at
their highest levels and then they drop daily due to cell
metabolism. These drops in values are increasing with
culture time as a result of the increase in cell concentra-
tions. The waste products concentrations (lactate and
ammonia) are generated as a result of glucose and glutamine
consumption, respectively. However, the specific metabolite
consumption rates and waste production rates were about
50% lower for MC due to the high cell numbers achieved
compared to 2D colony cultures, indicating a more efficient
metabolism in the former (data not shown). We have
routinely propagated MC beyond 23 passages which were
typically passaged weekly at a split ratio of 1:10, maintaining
over 90% viability, compared to 1:4 for 2D colony cultures.
Furthermore, HES-3 cells were adapted to grow in mTeSR1tic cultures). (a) Mechanically passaged hESC seeded onmatrigel-
rriers on Day 1 and grow into confluent multilayer aggregates by
within the cell aggregates. Scale bars, 1 mm. (b) Histological
en distribution of several layers of hESC around the microcarriers
TRA-1-60 staining evenly throughout the aggregates. Uncoated
and have weak TRA-1-60 marker staining. Dark arrows show
Passage 3. Scale bars, 100 μm. (c) hESC microcarrier aggregates
ocarrier aggregates, from which hESC colonies spread onto the
xpress high levels (N95%) of Oct4, SSEA4, and TRA-1-60 markers
control. (d) Consistently high cell densities ranging from 1.2 to
aging experiments were performed and representative data are
expressed in microcarrier cultures. Passage 9. Cells were stained
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Figure 1 (continued).
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223Long-term microcarrier suspension cultures of human embryonic stem cellsand StemPRO serum-free media on microcarriers beyond 20
passages (5 months). Normal karyotypes were observed at
passages 19 and 20, respectively (data not shown), and
pluripotent markers were maintained (Fig. 3c).
Suspension culture of hESC on microcarriers
Growth kinetics of hESC in a 50-ml spinner flask MC further
demonstrated that HES-3 cells achieved a superior density of
3.5 million cells/ml compared to the static microcarrier (1.5
million cells/ml) and the 2D colony (0.8 million cells/ml)
cultures (Fig. 4a). The doubling time of 21 h (specific growth
rate of 0.033 h-1) was also faster in the spinner flask culture
compared to the typical doubling times of 30 h for the static
MC and 33 h for the 2D colony culture. The faster cell growth
in spinner cultures may be attributed to better oxygen
transfer in the agitated environment. The reduction of cell
numbers on Day 5 onward could be due to cells detaching
from the densely populated aggregate cultures, media and
oxygen limitations, and low pH (b6.7) obtained at the higher
cell densities and may cause cells to enter the stationary or
death phase; thus it may be better to harvest the cells earlier
in the spinner cultures.
To assess long-term suspension culture, a second hESC
line, HES-2, was also passaged continuously for 7 weeks in 6-
well plates as static and agitated MC and compared to the 2D
colony control. Fig. 4b shows that both static and agitated MC
achieved significantly highermaximumcell densities than the
2D colony culture (Pb0.05). Pluripotent markers of Oct4,
TRA-1-60, and SSEA4 continue to be robustly expressed in the
static and agitated MC compared to the control (Fig. 4c).
Discussion
A variety of approaches have been taken by researchers for
the expansion of hESC and mouse embryonic stem cells
(mESC) on surfaces. For example, a Hamilton Robotics Cell
system has been developed to seed feeder layers into 6-well
plates and culture mESC and hESC colony cultures by
performing daily feeding (Terstegge et al., 2007). With the
development of enzymatic and monolayer-type cultures of
hESC, another group has demonstrated the ability to passage
hESC with trypsin under feeder-free conditions using the
CompacT SelecT for 10 passages (Thomas et al., 2009). This
platform has the potential to scale the process up to 90 T175
flasks. Such automation technologies will indeed help to
standardize hESC culture and expand them in sufficient
quantities for applications in drug toxicity screening and
discovery or production of cells for therapy (Thomson, 2007).
We have also demonstrated high density cultures of mESC on
petriperm culture surfaces capable of producing 5 to 30
times more cells per unit surface area with automated
feeding (Oh et al., 2005). It has also been shown that
perfusion feeding of hESC with feeder conditioned media was
able to improve the final cell numbers by 70% compared to
daily feeding (Fong et al., 2005). A different approach to cell
expansion has been taken by Ouyang and Yang who have
developed a two-stage perfusion fibrous bed bioreactor for
expansion of both mESC and hESC to exceptionally high cell
densities, where one bioreactor produced conditioned media
from feeders which fed the second bioreactor for theexpansion of ESC (Ouyang and Yang, 2008). However, one
limitation of this method could be the efficient harvesting of
cells from the fibrous bed for differentiation as well as mass
transfer limitations which will be encountered at very high
cell densities.
Despite the progress in automation technologies, the
limitation of growing ESC on surfaces is that the increase in
cell density is restricted to the available area. Therefore for
therapeutic applications, where very large volumes of cell
cultures may eventually be required, in liters per batch
production run, it is necessary to develop bioprocesses which
do not scale on 2D culture surfaces but rather in 3D
environments such as in suspension bioreactors. Some of
the early studies of expansion and differentiation of ESC used
mESC as a model system which has been reviewed by King
and Miller (2007). One group has expanded mESC in sus-
pension culture as controlled sized aggregates by 31-fold
over 5 days by controlling inoculum size and agitation rates
(Cormier et al., 2006). They further demonstrated that these
aggregates could be subcultured continuously for 7 passages
achieving 1 million cells/ml (zur Nieden et al., 2007). mESC
maintained pluripotent marker expression and their ability
to differentiate into embryoid bodies and form tissues
from three germ layers in teratomas. In another study,
mESCs cultured on glass microcarriers at 60 rpm in stirred-
suspension culture had population doubling times compa-
rable to those of tissue-culture flask controls (~14–17 h),
while mESC growth had longer doubling times ranging
between 24 and 39 h at 100 rpm impeller speed. On removal
of leukemia inhibitory factor, the size-controlled ESC aggre-
gates developed into embryoid bodies capable of multi-
lineage differentiation (Fok and Zandstra, 2005). Another
group used Cytodex-3 microcarriers in suspension bioreac-
tors and examined the optimal cell seeding density and
microcarrier concentrations on mESC expansion. Although
higher cell densities were achieved than in 2D cultures, there
was a short death phase before exponential growth; mESC
doubling times were longer than mESC grown on plastic
surfaces (Abranches et al., 2007).
Expansion of undifferentiated hESCs on microcarriers has
proven to be more difficult than for mESCs. However, expan-
sion of human feeders in suspension culture on Cytodex-3
microcarriers has been demonstrated and production of
conditioned media from these feeders supported hESC
growth for five passages (Phillips et al., 2008a). A recent
publication by the same group has also demonstrated proof
of concept of culturing hESC on microcarriers by seeding
aggregates as well as single cells. Initially, 3-fold expansion
was achieved over 5 days but with each successive passage,
cell expansion was reduced until cells could not be passaged
beyond Week 6 (Phillips et al., 2008b). More recently,
another group has established a dynamic process for the
formation, propagation, and differentiation of human em-
bryoid bodies in a variety of spinner cultures (Yirme et al.,
2008). The authors showed that glass ball impeller spinner
flasks resulted in the highest EB yield. However, this is
different from our approach which is the serial propagation
of undifferentiated hESC on MC. In this paper, we report for
the first time, a facile and robust method for maintaining
undifferentiated hESC in 3D suspension cultures on matrigel-
coated microcarriers which achieved 2- to 4-fold higher cell
densities than in 2D colony cultures. Stable, continuous
224 S.K.W. Oh et al.propagation of hESC on microcarriers has been demons-
trated in conditioned media and two serum-free defined
media (StemPro and mTeSR1) as well as with feeder cultures
(unpublished data).Based on the spinner flask data, MC achieved even higher
cell concentrations and has the potential to enable facile
expansion of hESC in larger volumes instead of expansion
on surfaces. For example, a 100-ml suspension culture can
Figure 2 Characterization of hESC on microcarriers: karyotype, RT-PCR of differentiation markers and differentiated tissues in tera-
toma. (a) Both HES-2 and HES-3 propagated onmicrocarriers were karyotyped by G-banding at passages 6, 14, 22, and 25. All cells showed
normal 46 XX karyotypes. Twenty metaphase spreads were counted per sample. Representative karyotypes at passages 14 and 25 are
shown. (b) Embryoid bodies formed from hESC cultured onmicrocarrier (passages 3 and 27) and 2D colony cultures express differentiation
markers from the three germ layers: amylase and GATA 6 from the endoderm; keratin and neurofilament from the ectoderm; and Msh
homeobox (MSX1) and heart and neural crest derivatives (HAND1) from the mesoderm. (c) Section of a teratoma from hESC cultured on
microcarriers indicating tissues from the three germ layers. (1) Bone, (2) gut-like epithelium, and (3) neural rosette. Scale bar, 300 μm.
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In the future, it would also be possible to further optimize
these cultures by controlling parameters such as pH,
dissolved O2, and feeding strategies in bioreactors. We are
also broadening the use of these microcarriers for other cell
lines such as human iPS cells and differentiation of hESC.
In summary, we have demonstrated that 3D MC can be a
simple, stable, and robust alternative method of culturing
hESC instead of 2D colony cultures. MC will be amenable to
scale up as controlled bioprocesses in bioreactors, and in the
future may also facilitate directed differentiation of hESC.
Materials and methods
hESC propagation in 2D cultures
hESC lines HES-2 and HES-3 (ES Cell International) were
routinely cultured at 37 °C/5% CO2 on matrigel-coated organculture dishes supplemented with conditioned media from
mouse feeders and passaged by enzymatic treatment as
previously described (Chin et al., 2007).
To passage hESC from 2D colony cultures to MC, cells
grown on a 6-cm tissue culture dish were harvested by
treatment with collagenase followed by pipetting to form
clumps less than 100 μm in diameter, typically ranging from
50 to 60 μm. Alternatively, a pipette or cell scraper
(Invitrogen) was used to create clumps less than 100 μm.
Cells were seeded at a density of 1 to 2× 105 cells/ml.
Microcarrier cultures of hESC in static and
agitated conditions
Cellulose microgranular cylindrical shape microcarriers were
used for hESC culture (Supplementary Fig. 1a). Microcarriers
were prepared in calcium- and magnesium-free phosphate
buffer saline and sterilized by autoclaving before use.
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(dilution 1:30 of Stock solution in KO medium) of Matrigel
Basement Membrane Matrix (Becton Dickinson) to 4 mg of
microcarriers. Coated and uncoated microcarriers were
incubated in KO medium at 4 °C overnight before use the
following day. hESC lines were cultured at 37 °C/5% CO2 on
ultralow attachment 6-well plates (Corning Cat. No. 3471) in
conditioned media or serum-free defined media StemPRO
(Invitrogen) or mTeSR1 (Stem Cell Technologies) under static
nonagitated or agitated conditions (100 rpm on the IKA
Orbital Shaker) and media were refreshed every 24 h. TheFigure 3 Growth kinetics and metabolism of HES-3 hESC static m
Typical growth curves of hESC in 2D colony vs microcarrier cultures. S
with 0.13×106 cells/ml in 2D colony and microcarrier cultures (4 m
monitoring of metabolites. (b) Glutamine, glucose, lactate, and amm
from 2D colony and microcarrier cultures. (c) HES-3 hESC after 20 p
microcarriers retained stable Oct4, SSEA4, and TRA-1-60 expression
were stained with SSEA-1 as the isotype control.cultures were routinely passaged weekly at a split ratio of 1:5
to 1:10 depending on the final cell densities. Cells were
seeded at 1 to 2×105 cells/ml. Cell counts and FACS were
taken on Days 0 and 7.
Cells were passaged by enzymatic and mechanical
methods. Enzymatic: MC were treated with 2 ml TrypLE
Express or collagenase (Invitrogen) and pipetting to
generate single cells or cell clumps. Cells were pelleted
at 500 g for 5 min and resuspended in conditioned medium
before seeding into a 6-well plate with microcarriers.
Mechanical: MC was broken into small clumps with gentleicrocarrier cultures in conditioned and serum-free media. (a)
ix-well plates containing 5 ml of conditioned media were seeded
g/ml). Duplicate wells were harvested daily for cell counts and
onium concentrations of the spent media were measured daily
assages (5 months) in StemPro and mTeSR1 serum-free media on
. Representative FACS of these three markers are shown. Cells
Figure 3 (continued).
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To eliminate larger clumps, the sample was dispensed
either through a 100-μm (BD Falcon Cell Strainers Cat. No.
352360) or 500-μm mesh (24 mm Netwell Insert with 500-
μm Mesh Size Polyester Membrane, Corning Cat. No. 3480)
before seeding new microcarriers or reseeding 2D colony
cultures.Microcarrier spinner flask cultures
Mechanically dissociated hESC obtained from static MC were
seeded at a density of 6×105 cells/ml into a presiliconized
(Sigmacote, Sigma-Aldrich) 100-ml Bellco spinner flask (Cat.
No. 1965-00100) containing 4 mg/ml of microcarriers in 25 ml
of conditioned medium. The culture was incubated inside a
controlled incubator at 37 °C and 5% CO2 at initial agitation
speed of 15 rpm. After 1 day the medium was topped up to
50 ml and agitation speed was increased to 25 rpm; 80% of
the spent medium was removed daily and replaced with fresh
CM. Daily samples were taken for cell counts and FACS
analysis was performed after 7 days.Cell counts
hESC were harvested daily as a single cell suspension after
treatment with TrypLE Express or mechanical dissociation
followed by enzymatic treatment in MC. Cell numbers were
determined by nuclei counts after cell lysis and propidium
iodide staining using the Nucleocounter (Chemometec). Cell
viability was determined by trypan blue staining. Specificgrowth rate was calculated as μ= ln (x1–x2) / t1–t2. Time
points were taken over the exponential growth phase
typically between Days 2 and 5.Metabolic measurements
Monitoring of cell metabolism was done by obtaining super-
natant samples on a daily basis to measure the glucose,
glutamine, lactic acid, and ammonium concentrations (NOVA
Bioprofile 100 plus).FACS analysis
Expression levels of the intracellular transcription factor
Oct4 and extracellular antigens SSEA4 and TRA-1-60 in
hESC populations were assessed by immunofluorescence
using flow cytometry. Cells were harvested as a single cell
suspension using TrypLE Express. In the case of micro-
carriers, they were filtered through a 40-μm sieve (BD)
following treatment with the enzyme. Cells were fixed,
permeabilized (Fix and Perm Cell Permeabilization
reagents (Invitrogen)), and incubated with mouse primary
antibodies Oct4 (Santa Cruz) at a 1:20 dilution, SSEA4
(Developmental Studies Hybridomas Bank) at a 1:1 dilution
and TRA-1-60 (Chemicon) at a 1:50 dilution. Cells were
subsequently washed with 1% BSA/PBS, and incubated in
the dark with a 1:500 dilution of goat anti-mouse antibody
FITC-conjugated (DAKO). After washing in 1% BSA/PBS cells
were analyzed on a FACScan (Becton Dickinson FACS
Calibur). As a negative control the cells were stained
Figure 4 Suspension microcarrier cultures of HES-3 and HES-2 in conditioned media. (a) Growth kinetics of microcarrier culture in
50-ml spinner flask show that higher cell density (3.5×106 cells/ml) was achieved in suspension microcarrier cultures than static
microcarriers (1.5×106 cells/ml) or 2D colony controls (0.8×106 cells/ml). HES-3 suspension cultures achieved N4 times higher cell
densities compared to the 2D colony control. Triplicate experiments were performed and representative data are shown. (b) 2D
colony, static microcarrier, and agitated microcarrier cultures were seeded between 0.4 and 1×105 cells/ml and passaged every 7
days. HES-2 static and agitated microcarrier cultures achieved N2 times higher cell densities compared to 2D colony controls
(⁎ indicates significant increase in cell densities over 2D colony controls, Student's t test, Pb0.05, n=7). Data presented are an
average of 7 experiments. (c) FACS analyses of static and agitated microcarrier cultures show similar expression levels of pluripotent
markers Oct4, SSEA4, and TRA-1-60 to 2D colony controls. Passage 5.
228 S.K.W. Oh et al.with SSEA-1 as the isotype control. Gates were typically set
at the point of intersection between the negative and the
positive stains, after which the percentage of cells from
the negative control within the gate was subtracted from
the positive.Immunohistochemistry
MC were fixed with 4% paraformaldehyde, embedded in
paraffin, and stained with DAPI or mouse primary antibodies
to TRA-1-60 for 1 h and goat anti-mouse antibody FITC-
229Long-term microcarrier suspension cultures of human embryonic stem cellsconjugated for 1 h and viewed under a fluorescence
microscope (Leica).
Karyotyping
Actively growing cultures of hESC either from 2D colony or
from replated MC were arrested in the metaphase stage
following incubation with colcemid solution. For each
condition, 20 metaphase spreads were examined. Cytoge-
netics analysis was performed at the Cytogenetics Labs at
the KK Women's and Children's hospital, Singapore.
RT-PCR and teratoma assays
Cells from MC were replated onto matrigel-coated dishes. To
induce differentiation, hESC were harvested as clumps from
2D colony or replated MC. The harvested clumps were
cultured as embryoid bodies for 8 days in EB medium on
nonadherent dishes and subsequently replated on gelatinized
dishes for another 14 days. Total RNA was extracted in Trizol
and RT-PCR was performed as previously published using
primers specific to actin, amylase, GATA6, keratin, neurofila-
ment, MSX1, and HAND1 (Chin et al., 2007). Teratomas were
formed by injecting 4–5 million cells harvested either from
2D colony or from replated MC into the rear leg muscle of
4-week-old female SCIDmice. After 9–10weeks, tumorswere
dissected, fixed, stained with hematoxylin and eosin, and
examined histologically. Animal experiments were performed
in accordance with NIH and NACLAR guidelines (NUS IRB
protocol 05-020, Biopolis IACUC approval 050008).
Differentiation to cardiomyocytes
To induce differentiation, MC of hESC were cultured for 6
days in CM, washed three times with basal media, and then
transferred to serum-free chemically defined media for car-
diomyocyte induction (Xu et al., 2008). After 9 days, beating
aggregates were formed.
Statistical analysis
All experiments were performed minimally in duplicates and
data presented were representative of at least duplicate
experiments under different culture conditions. Statistical
significance was determined using Student's t tests with a
significance level of Pb0.05.Acknowledgments
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